Browsed by
Tag: Psilocybin Therapy

New Zealand’s Psilocybin Prescription Policy: A Cautious Step Towards Novel Depression Treatment

New Zealand’s Psilocybin Prescription Policy: A Cautious Step Towards Novel Depression Treatment

New Zealand’s Psilocybin Prescription Policy: A Cautious Step Towards Novel Depression Treatment New Zealand has taken a significant, albeit cautious, step towards exploring the therapeutic potential of psilocybin, a psychedelic compound found in certain mushroom species, for the treatment of depression. Deputy Prime Minister David Seymour recently announced a relaxation of regulations, allowing for the prescription of psilocybin under strictly controlled conditions to patients suffering from treatment-resistant depression. While psilocybin remains an unapproved medicine in New Zealand, a highly experienced…

Read More Read More

Cancer Patients Find Lasting Relief from Depression with Psilocybin Therapy

Cancer Patients Find Lasting Relief from Depression with Psilocybin Therapy

Cancer Patients Find Lasting Relief from Depression with Psilocybin Therapy Imagine a single treatment offering lasting relief from the crushing weight of depression. For cancer patients battling depression, that reality is closer than ever thanks to a groundbreaking study published in Cancer. Researchers from Sunstone Therapies conducted a phase 2 trial involving 30 cancer patients also diagnosed with major depressive disorder. The study explored the impact of a single dose of psilocybin, combined with psychological support, on depression and anxiety….

Read More Read More

Long-Term Efficacy of Psilocybin-Assisted Psychotherapy for Cancer-Related Depression: A Two-Year Follow-Up Study

Long-Term Efficacy of Psilocybin-Assisted Psychotherapy for Cancer-Related Depression: A Two-Year Follow-Up Study

Long-Term Efficacy of Psilocybin-Assisted Psychotherapy for Cancer-Related Depression: A Two-Year Follow-Up Study A recent phase 2 clinical trial published in Cancer offers compelling evidence regarding the long-term efficacy of psilocybin-assisted psychotherapy in treating major depressive disorder (MDD) among cancer patients. The study, conducted by researchers at Sunstone Therapies and colleagues, followed 30 participants with cancer and MDD for two years after a single dose of psilocybin combined with psychological support. The results demonstrate significant and sustained improvements in both depression…

Read More Read More